Frauenfeld, 10 April 2025 Press release Ad hoc announcement pursuant to Art. 53 LR DocMorris accelerates Rx growth to 52 per cent and secures CHF 200 million capital increase through firm underwriting DocMorris grows by 13.4 per cent across all business areas in the first quarter Rx revenue increase by 52.3 per cent TeleClinic enters next sc [ … ]

Frauenfeld, 13 March 2025 These written materials or the information contained therein is not being issued and may not be distributed in the United States of America, Canada, Australia or Japan or any other jurisdiction in which the distribution or release would be unlawful or require registration or any other measure and does not constitute an of [ … ]

Frauenfeld, 27 February 2025 Press release Ad hoc announcement pursuant to Art. 53 LR ECJ Ruling on advertising for prescription medicines The European Court of Justice (ECJ) today answered the questions referred by the German Federal Court of Justice (BGH) in Case C-517/23 / Apothekerkammer Nordrhein (AKNR). The ECJ continues to consider pric [ … ]

DocMorris AG / Key word(s): Development of Sales DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter 21.01.2025 / 06:58 CET/CEST Frauenfeld, 21 January 2025 Press release DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter All business divisions contri [ … ]